查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2000747

醫用手套市場：按材料類型、無菌狀態、厚度、長度、尺寸、銷售管道和應用分類－2026-2032年全球市場預測

Medical Gloves Market by Material Type, Sterility, Thickness, Length, Fit, Distribution Channel, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫用手套市場價值將達到 153.9 億美元，到 2026 年將成長至 164.9 億美元，到 2032 年將達到 274.7 億美元，複合年成長率為 8.62%。

主要市場統計數據
基準年 2025 153.9億美元
預計年份：2026年 164.9億美元
預測年份 2032 274.7億美元
複合年成長率 (%) 8.62%

策略指南明確了相關人員的優先事項、供應鏈的現狀、監管壓力以及醫用手套分析的實際目標。

醫用手套產業處於臨床安全、營運連續性和生產韌性的交匯點。本導言全面概述了該行業，闡明了需求的關鍵促進因素、影響供應的供應鏈限制因素，以及決定專業領域產品整體情況的監管和採購框架。透過明確範圍和相關人員的優先事項，讀者將能夠更好地理解後續章節的背景和目的。

材料創新、更嚴格的法規、不斷變化的分銷管道以及供應鏈的韌性如何重新定義了整個醫用手套生態系統的戰略重點。

受材料創新、感染控制要求不斷提高以及供應鏈實踐不斷演進的推動，醫用手套市場經歷了變革性變化。醫用級丁腈化合物因其優於傳統乳膠產品，具有更優異的耐化學性、舒適性和降低致敏性，迅速成為重要的技術材料。同時，在對成本和觸感要求不高的領域，乙烯基材料仍然佔據重要地位。由此形成了一個由多種材料所構成、性能取捨並存的市場生態系。

關稅帶來的成本和物流壓力正在推動供應多元化、對近岸外包的投資以及合約策略，以維持業務永續營運和獲利能力。

近期關稅政策的調整為手套的採購和生產帶來了切實的經濟和物流方面的摩擦。關稅措施提高了加工商和成品供應商對原料成本的敏感度，促使許多公司重新評估籌資策略，並加快對近岸外包和本地生產的投資。因此，整個價值鏈都在重新評估成本與可靠性之間的平衡。

詳細的細分分析解釋了應用、材料、通路、無菌性、厚度、長度、合身度和尺寸如何相互交織，從而影響採購和產品策略。

基於細分市場的洞察揭示了應用、材料選擇、通路、滅菌等級、厚度標準、長度變化、貼合方式和尺寸選項如何造就不同的需求細分和營運要求。按應用領域分類，市場研究涵蓋食品服務、醫療、工業和實驗室等領域，每個領域都有其獨特的性能標準，從簡單的衛生控制到關鍵的屏障保護和耐化學腐蝕性。依材料類型分類，市場研究涵蓋乳膠、丁腈橡膠和聚氯乙烯領域，這些材料針對不同的使用者風險、過敏原考量和成本績效平衡，進而影響產品規格的發展。

影響美洲、歐洲、中東和非洲以及亞太市場生產基地選擇、監管方式和採購行為的區域趨勢。

區域趨勢持續影響全球手套市場的生產地點、監管重點和買家行為。在美洲，採購流程透明度、供應商合格以及對本地檢驗供應鏈的偏好日益增強，反映了區域自力更生和增強韌性的更廣泛趨勢。這種區域背景正推動對本地加工能力的投資，並促進製造商與機構買家之間更緊密的夥伴關係，以降低前置作業時間風險。

競爭動態揭示了技術差異化、檢驗製造和夥伴關係為中心的經銷模式如何決定與機構的長期關係。

該領域的主要企業透過整合材料科學專業知識、檢驗的生產流程和靈活的分銷管道來脫穎而出。領先的製造商已投資於先進的丁腈橡膠配方和製程控制，以降低缺陷率並提升觸感性能。這些投資輔以生產認證和強化的品管體系，從而增強了買家的信心並促進了機構合約的簽訂。

在快速變化的環境中，製造商和經銷商需要採取具體的策略重點來增強韌性、提高產品效能並深化與機構的夥伴關係。

產業領導企業應優先採取一系列切實可行的措施，以增強自身韌性、提高成本績效，並在快速變化的採購環境中加速差異化。首先，將產品研發投資與臨床主導的效能指標結合，可確保創新能夠解決使用者面臨的實際挑戰，並為其高階定位提供基礎。這意味著優先選擇那些在手術應用中能夠最佳化觸覺靈敏度、同時降低過敏風險並增強耐化學性的材料。

一個透明的混合方法研究框架，整合了初步訪談、監管分析和細分市場比較評估，以得出可操作的結論。

本調查方法整合了多種證據來源，以確保分析的嚴謹性、透明度和與實際營運決策的相關性。主要證據來源包括對臨床採購經理、供應鏈經理、產品開發工程師和分銷主管進行結構化訪談，以收集關於規格決定因素、供應限制和服務期望的第一手觀點。次要證據來源包括對監管指南、無菌性和屏障性能標準以及支撐產品差異化的材料特性等相關文獻資料的系統性審查。

一項綜合策略洞察，重點闡述了為什麼檢驗的績效、供應柔軟性和諮詢式分銷將決定未來的永續競爭優勢。

總之，醫用手套產業正處於戰略轉折點，材料進步、監管趨嚴、分銷創新和貿易動態的相互作用正在重新定義競爭優勢。那些優先考慮產品效能檢驗、供應鏈柔軟性和諮詢式分銷模式的企業，將更有能力滿足臨床和非臨床買家日益成長的期望。監管合規和採購透明度的雙重壓力，正在加速推動整個價值鏈對品質和可追溯性的文件化需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 醫用手套市場：依材料類型分類

  • 乳膠
  • 丁腈橡膠
  • 乙烯基塑膠

第9章：以滅菌狀態分類的醫用手套市場

  • 非無菌
  • 已滅菌

第10章：以厚度分類的醫用手套市場

  • 無粉
  • 粉狀

第11章 依長度分類的醫用手套市場

  • 長款
  • 標準長度

第12章：依合身度分類的醫用手套市場

  • 雙手
  • 分開左右兩邊

第13章 醫用手套市場：依通路分類

  • 離線
    • 醫院藥房
    • 醫療批發商
    • 零售藥房
  • 線上

第14章 醫用手套市場：依應用領域分類

  • 食品服務業
  • 衛生保健
  • 工業的
  • 實驗室

第15章 醫用手套市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 醫用手套市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 醫用手套市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國醫用手套市場

第19章：中國醫用手套市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Amazing Rubber Products Pvt. Ltd.
  • Amigo Surgir-care Pvt. Ltd.
  • Amkay Products Limited
  • AMMEX Corporation
  • Ansell Healthcare Products LLC
  • Armbrust American
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Cranberry International Sdn Bhd
  • Dynarex Corporation
  • Hartalega Holdings Berhad
  • INTCO Medical
  • Kanam Latex Industries Pvt. Ltd.
  • Kimberly-Clark Corporation
  • Kossan Rubber Industries Bhd.
  • McKesson Corporation
  • Medline Industries, LP
  • Molnlycke Health Care
  • Paul Hartmann AG
  • RFB Latex Limited.
  • Rubberex（M）Sdn Bhd
  • Semperit AG Holding
  • Sempermed
  • Supermax Corporation Bhd
  • Top Glove Corporation Bhd
Product Code: MRR-02026C4C9519

The Medical Gloves Market was valued at USD 15.39 billion in 2025 and is projected to grow to USD 16.49 billion in 2026, with a CAGR of 8.62%, reaching USD 27.47 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.39 billion
Estimated Year [2026] USD 16.49 billion
Forecast Year [2032] USD 27.47 billion
CAGR (%) 8.62%

A strategic orientation that defines stakeholder priorities, supply chain realities, regulatory pressures, and the practical purpose of the medical gloves analysis

The medical gloves sector sits at the nexus of clinical safety, operational continuity, and manufacturing resilience. This introduction frames the landscape by clarifying the primary drivers that shape demand, the supply chain constraints that influence availability, and the regulatory and procurement frameworks that determine product selection across professional settings. By establishing a concise scope and defining stakeholder priorities, the reader is equipped to interpret subsequent sections with context and purpose.

Clinicians, procurement leaders, facility managers, and manufacturing executives all operate under overlapping but distinct pressures: infection prevention and user safety, cost containment and inventory reliability, and product performance across multiple use cases. This introduction delineates those priorities and highlights the interplay between material science, regulatory compliance, and distribution logistics. It also underscores why granular segmentation and regional dynamics matter to strategy development, setting the stage for the analysis that follows.

Finally, the introduction clarifies the intended application of the insights: to inform sourcing decisions, product development roadmaps, and risk mitigation strategies. The aim is to provide a pragmatic foundation so that readers transition quickly from situational awareness to tactical actions that improve resilience, reduce operational friction, and enhance protective outcomes for end users.

How materials innovation, regulatory tightening, distribution evolution, and supply chain resilience have jointly reshaped strategic priorities across the medical gloves ecosystem

The medical gloves landscape has undergone transformative shifts driven by materials innovation, heightened infection-control expectations, and evolving supply chain practices. Medical-grade nitrile formulations surged in technical prominence as they delivered superior chemical resistance, wearer comfort, and allergy mitigation compared with traditional latex options. Concurrently, vinyl maintains relevance where low cost and minimal tactile demands predominate, creating a multi-material product ecosystem shaped by performance trade-offs.

Regulatory regimes have tightened quality assurance pathways, accelerating adoption of sterility controls and traceability mechanisms. These developments have forced manufacturers and distributors to rethink production validation and documentation processes, while purchasers have prioritized supplier transparency. At the same time, the expansion of online procurement platforms has altered buying patterns, enabling smaller healthcare facilities and non-hospital end users to access a broader product mix and competitive pricing dynamically.

Supply chain resilience has shifted from a sole focus on cost to a balanced emphasis on diversified sourcing, inventory visibility, and contingency manufacturing capacity. Investment in local converting capacity and strategic inventory hubs has reduced single-point dependencies. Together, these factors have raised the bar for product specifications, commercial engagement, and partnership models between buyers and suppliers, making adaptability and technical differentiation central to competitive advantage.

Tariff-induced cost and logistics pressures that are prompting supply diversification, nearshoring investments, and contract strategies to preserve continuity and margins

Recent tariff policy adjustments have introduced tangible friction into the economics and logistics of glove procurement and manufacturing. Tariff measures have increased input cost sensitivity for converters and finished-goods suppliers, prompting many firms to reevaluate sourcing strategies and to accelerate nearshoring or regional manufacturing investments. The result has been a rebalancing of cost versus reliability considerations across the value chain.

Import duties have also influenced inventory planning and lead-time management. Organizations that previously relied on just-in-time replenishment have had to adapt to extended procurement cycles or absorb higher landed costs when priority delivery was required. These dynamics have encouraged longer-term supplier agreements and volume commitments to mitigate tariff volatility and secure consistent supply. Concurrently, some buyers have shifted toward higher-value, performance-driven products where incremental cost increases can be offset by improved clinical outcomes and reduced downstream incidents.

On the manufacturing side, tariff impacts have catalyzed investments in automation, process efficiency, and product differentiation to preserve margins. Companies with diversified product portfolios and flexible production lines have been better able to reprice selectively and to protect lower-margin segments. Overall, tariff-induced change has reinforced the importance of supply chain agility, contractual flexibility, and strategic sourcing as core competencies for both suppliers and purchasers.

Deep segmentation analysis explaining how application, material, channel, sterility, thickness, length, fit, and size intersect to shape procurement and product strategy

Segmentation-driven insight reveals how distinct applications, material choices, distribution pathways, sterility classifications, thickness conventions, length variants, fit paradigms, and size options create differentiated demand pools and operational requirements. Based on Application, market is studied across Food Service, Healthcare, Industrial, and Laboratory, each of which imposes unique performance criteria ranging from simple hygiene to critical barrier protection and chemical resistance. Based on Material Type, market is studied across Latex, Nitrile, and Vinyl, and these materials map to different user risks, allergen considerations, and cost-performance balances that influence specification decisions.

Based on Distribution Channel, market is studied across Offline and Online, with Offline further distinguished by Hospital Pharmacy, Medical Distributor, and Retail Pharmacy; these channels vary in procurement rigor, buying cadence, and packaging formats, affecting everything from minimum order quantities to documentation expectations. Based on Sterility, market is studied across Non-Sterile and Sterile, and the choice between them hinges on clinical risk profile and regulatory mandates. Based on Thickness, market is studied across Non-Powdered and Powdered, where powder use intersects with handling comfort and contamination risk tolerance.

Based on Length, market is studied across Extended Length and Standard Length, impacting ergonomic fit for specific procedural tasks. Based on Fit, market is studied across Ambidextrous and Hand Specific, which directly affects inventory complexity and user satisfaction. Based on Size, market is studied across Extra Large, Large, Medium, and Small, and size distribution reflects workforce demographics and specialty needs. Pulling these segmentation axes together clarifies where value-for-performance trade-offs are most acute and where targeted product innovation or channel strategies can unlock operational gains.

Regional dynamics that drive production location choices, regulatory approaches, and procurement behavior across the Americas, EMEA, and Asia-Pacific markets

Regional dynamics continue to shape production footprints, regulatory priorities, and buyer behavior across the global glove landscape. Americas markets emphasize procurement transparency, supplier qualification, and a growing preference for locally validated supply chains, reflecting a broader trend toward regional self-reliance and resilience. This regional context has encouraged investments in regional converting capabilities and closer partnerships between manufacturers and institutional buyers to reduce lead-time risk.

Europe, Middle East & Africa display heterogeneous demand driven by stringent regulatory frameworks in parts of Europe and evolving healthcare infrastructure in the Middle East and Africa. This diversity necessitates adaptive commercial strategies: premium, certified products for highly regulated markets and cost-effective solutions with clear safety benchmarks for emerging care settings. Meanwhile, the region's logistics corridors and trade agreements influence where manufacturers position inventory and how distributors structure their service offerings.

Asia-Pacific remains a pivotal node for both raw material supply and finished-goods production, with established manufacturing clusters and ongoing investments in technical conversion capacity. Emerging markets in the region are driving localized demand growth and encouraging manufacturers to tailor product specifications to regional clinical practices and procurement norms. Across all regions, regulatory alignment, logistics efficiency, and strategic inventory placement are decisive factors that determine how companies compete and collaborate.

Competitive dynamics revealing how technical differentiation, validated manufacturing, and partnership-oriented distribution models determine long-term institutional relationships

Key companies in the sector differentiate through a combination of material science expertise, validated manufacturing processes, and distribution agility. Leading producers have invested in advanced nitrile formulations and process controls that reduce defect rates and improve tactile performance. These investments have been complemented by manufacturing certifications and enhanced quality management systems that support purchaser confidence and facilitate institutional contracts.

Distributors and value-added resellers have evolved from logistics providers into consultative partners, offering supplier qualification services, custom packaging, and inventory management programs. Strategic collaborations between producers and channel partners have enabled bundled offerings that simplify procurement for large healthcare systems while providing traceability and technical support. Meanwhile, smaller or regionally focused firms compete by emphasizing nimble responsiveness, localized service, and targeted product portfolios that align tightly with specific end-user needs.

Across the competitive landscape, success increasingly hinges on the ability to demonstrate validated performance, maintain supply continuity under shifting trade conditions, and provide transparent documentation that satisfies regulatory and clinical stakeholders. Organizations that combine technical differentiation with partnership-oriented distribution models are best positioned to capture long-term institutional relationships.

Concrete strategic priorities for manufacturers and distributors to strengthen resilience, enhance product performance, and deepen institutional partnerships in a dynamic environment

Industry leaders should prioritize a set of actionable moves that strengthen resilience, improve cost-to-performance ratios, and accelerate differentiation in fast-evolving procurement environments. First, aligning product development investments with clinically driven performance metrics will ensure that innovations address real user pain points and justify premium positioning. This means prioritizing materials that reduce allergy risk and increase chemical resistance while optimizing tactile sensitivity for procedural use.

Second, building supply chain flexibility is essential. Leaders should adopt multi-sourcing approaches, invest in regional converting capacity where feasible, and formalize contingency inventory and contract terms to manage tariff and logistics volatility. Third, elevating distribution engagement through improved documentation, digital procurement interfaces, and value-added services will enhance buyer trust and reduce procurement friction for institutional purchasers. Fourth, integrate data-driven quality assurance and traceability systems to meet increasingly rigorous regulatory expectations and to provide clients with auditable product provenance.

Finally, cultivate commercial models that combine long-term institutional agreements with agile service offerings for emergent needs, thereby smoothing revenue volatility and deepening customer relationships. These combined actions create a defensible competitive posture that balances margin preservation, operational reliability, and differentiated product performance.

A transparent mixed-methods research framework that synthesizes primary interviews, regulatory analysis, and comparative segment evaluation to support actionable conclusions

The research methodology integrates multiple evidence streams to ensure analytical rigor, transparency, and relevance to operational decision-making. Primary inputs include structured interviews with clinical procurement leaders, supply chain managers, product development engineers, and distribution executives to capture firsthand perspectives on specification drivers, supply constraints, and service expectations. Secondary inputs involve a systematic review of regulatory directives, standards for sterility and barrier performance, and documented material properties that underpin product differentiation.

Analytical techniques combine qualitative thematic analysis with quantitative reconciliation of observed procurement behaviors, inventory practices, and distribution channel dynamics. Cross-validation was applied by triangulating interview findings with publicly available regulatory guidance and industry practice patterns. Regional and segment-level insights were distilled through comparative analysis to surface where policy, logistics, and clinical priorities diverge.

Throughout the process, emphasis was placed on traceability of claims and reproducibility of methods so that stakeholders can interrogate the basis for recommendations. Limitations were acknowledged where proprietary commercial data were unavailable, and sensitivity to policy or tariff changes was built into scenario narratives to help readers interpret how evolving conditions could alter strategic choices.

Synthesis of strategic implications highlighting why validated performance, supply flexibility, and consultative distribution define sustainable competitive advantage going forward

In conclusion, the medical gloves sector is at a strategic inflection point where material evolution, regulatory rigor, distribution innovation, and trade dynamics interact to redefine competitive advantage. Organizations that emphasize validated product performance, supply chain flexibility, and consultative distribution models will be better positioned to meet the rising expectations of clinical and non-clinical buyers alike. The combined pressures of regulatory compliance and procurement transparency are accelerating the need for documented quality and traceability across the value chain.

Operationally, the shift toward regional resilience and diversified sourcing is likely to persist, encouraging investments in localized converting capacity and in logistics infrastructure that shorten lead times. Commercially, product differentiation rooted in demonstrable clinical benefits will enable premium positioning for solutions that reduce downstream clinical risk. Taken together, these trends call for an integrated strategy that aligns product innovation, supply chain design, and customer engagement to deliver consistent protective performance and reliable availability.

Decision-makers who incorporate these insights into procurement, development, and partnership planning will be better equipped to navigate ongoing volatility and to capture long-term value from both institutional and emerging end-user segments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Gloves Market, by Material Type

  • 8.1. Latex
  • 8.2. Nitrile
  • 8.3. Vinyl

9. Medical Gloves Market, by Sterility

  • 9.1. Non-Sterile
  • 9.2. Sterile

10. Medical Gloves Market, by Thickness

  • 10.1. Non-Powdered
  • 10.2. Powdered

11. Medical Gloves Market, by Length

  • 11.1. Extended Length
  • 11.2. Standard Length

12. Medical Gloves Market, by Fit

  • 12.1. Ambidextrous
  • 12.2. Hand Specific

13. Medical Gloves Market, by Distribution Channel

  • 13.1. Offline
    • 13.1.1. Hospital Pharmacy
    • 13.1.2. Medical Distributor
    • 13.1.3. Retail Pharmacy
  • 13.2. Online

14. Medical Gloves Market, by Application

  • 14.1. Food Service
  • 14.2. Healthcare
  • 14.3. Industrial
  • 14.4. Laboratory

15. Medical Gloves Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Medical Gloves Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Medical Gloves Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Medical Gloves Market

19. China Medical Gloves Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Amazing Rubber Products Pvt. Ltd.
  • 20.6. Amigo Surgir-care Pvt. Ltd.
  • 20.7. Amkay Products Limited
  • 20.8. AMMEX Corporation
  • 20.9. Ansell Healthcare Products LLC
  • 20.10. Armbrust American
  • 20.11. B. Braun Melsungen AG
  • 20.12. Cardinal Health, Inc.
  • 20.13. Cranberry International Sdn Bhd
  • 20.14. Dynarex Corporation
  • 20.15. Hartalega Holdings Berhad
  • 20.16. INTCO Medical
  • 20.17. Kanam Latex Industries Pvt. Ltd.
  • 20.18. Kimberly-Clark Corporation
  • 20.19. Kossan Rubber Industries Bhd.
  • 20.20. McKesson Corporation
  • 20.21. Medline Industries, LP
  • 20.22. Molnlycke Health Care
  • 20.23. Paul Hartmann AG
  • 20.24. RFB Latex Limited.
  • 20.25. Rubberex (M) Sdn Bhd
  • 20.26. Semperit AG Holding
  • 20.27. Sempermed
  • 20.28. Supermax Corporation Bhd
  • 20.29. Top Glove Corporation Bhd

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL GLOVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL GLOVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL GLOVES MARKET SIZE, BY FIT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL GLOVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL GLOVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL GLOVES MARKET SIZE, BY LATEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL GLOVES MARKET SIZE, BY LATEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL GLOVES MARKET SIZE, BY LATEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL GLOVES MARKET SIZE, BY NITRILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL GLOVES MARKET SIZE, BY NITRILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL GLOVES MARKET SIZE, BY NITRILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL GLOVES MARKET SIZE, BY VINYL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL GLOVES MARKET SIZE, BY VINYL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL GLOVES MARKET SIZE, BY VINYL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL GLOVES MARKET SIZE, BY NON-STERILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL GLOVES MARKET SIZE, BY NON-STERILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL GLOVES MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL GLOVES MARKET SIZE, BY STERILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL GLOVES MARKET SIZE, BY STERILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL GLOVES MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL GLOVES MARKET SIZE, BY NON-POWDERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL GLOVES MARKET SIZE, BY NON-POWDERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL GLOVES MARKET SIZE, BY NON-POWDERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL GLOVES MARKET SIZE, BY POWDERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL GLOVES MARKET SIZE, BY POWDERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL GLOVES MARKET SIZE, BY POWDERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL GLOVES MARKET SIZE, BY EXTENDED LENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL GLOVES MARKET SIZE, BY EXTENDED LENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL GLOVES MARKET SIZE, BY EXTENDED LENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL GLOVES MARKET SIZE, BY STANDARD LENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL GLOVES MARKET SIZE, BY STANDARD LENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL GLOVES MARKET SIZE, BY STANDARD LENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL GLOVES MARKET SIZE, BY AMBIDEXTROUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL GLOVES MARKET SIZE, BY AMBIDEXTROUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL GLOVES MARKET SIZE, BY AMBIDEXTROUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL GLOVES MARKET SIZE, BY HAND SPECIFIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL GLOVES MARKET SIZE, BY HAND SPECIFIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL GLOVES MARKET SIZE, BY HAND SPECIFIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL GLOVES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL GLOVES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL GLOVES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL GLOVES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL GLOVES MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL GLOVES MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL GLOVES MARKET SIZE, BY MEDICAL DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL GLOVES MARKET SIZE, BY MEDICAL DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL GLOVES MARKET SIZE, BY MEDICAL DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL GLOVES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL GLOVES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL GLOVES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL GLOVES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL GLOVES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL GLOVES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL GLOVES MARKET SIZE, BY FOOD SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL GLOVES MARKET SIZE, BY FOOD SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL GLOVES MARKET SIZE, BY FOOD SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL GLOVES MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL GLOVES MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL GLOVES MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL GLOVES MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL GLOVES MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL GLOVES MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL GLOVES MARKET SIZE, BY LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL GLOVES MARKET SIZE, BY LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL GLOVES MARKET SIZE, BY LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL GLOVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS MEDICAL GLOVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA MEDICAL GLOVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL GLOVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. GCC MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GCC MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. GCC MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 156. GCC MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 157. GCC MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 158. GCC MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 159. GCC MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. GCC MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 161. GCC MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. G7 MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. G7 MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. G7 MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 183. G7 MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 184. G7 MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 185. G7 MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 186. G7 MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. G7 MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 188. G7 MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. NATO MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. NATO MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. NATO MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 192. NATO MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 193. NATO MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 194. NATO MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 195. NATO MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. NATO MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 197. NATO MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA MEDICAL GLOVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA MEDICAL GLOVES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA MEDICAL GLOVES MARKET SIZE, BY THICKNESS, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA MEDICAL GLOVES MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA MEDICAL GLOVES MARKET SIZE, BY FIT, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA MEDICAL GLOVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA MEDICAL GLOVES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA MEDICAL GLOVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)